CIK 0000882796 · Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 621413174
- Phone
- 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-01 | Jones Michael L Exec. Director, Finance - PAO | Option exercise | +2,300 | $4.73 | $11K | 13,498 |
| 2022-03-01 | Jones Michael L Exec. Director, Finance - PAO | Sale | −2,300 | $17.20 | $40K | 11,198 |
| 2022-03-01 | Jones Michael L Exec. Director, Finance - PAO | Option exercise · Emp. Stock Option (Right to Buy) | −2,300 | 0 | ||
| 2022-02-28 | LEVIN ALAN G Director | Grant or award | +602 | $16.61 | $10K | 2,059 |
| 2022-02-28 | INGRAM ROBERT ALEXANDER Director | Grant or award | +1,128 | $16.61 | $19K | 80,060 |
| 2022-02-28 | HEGGIE THERESA Director | Grant or award | +602 | $16.61 | $10K | 16,225 |
| 2022-02-28 | ASELAGE STEVE Director | Grant or award | +301 | $16.61 | $5K | 33,159 |
| 2022-02-15 | ABERCROMBIE GEORGE B Director | Option exercise | +5,000 | $3.32 | $17K | 5,000 |
| 2022-02-15 | ABERCROMBIE GEORGE B Director | Sale | −5,000 | $18.50 | $93K | 0 |
| 2022-02-15 | ABERCROMBIE GEORGE B Director | Option exercise · Automatic Stock Option Grant | −5,000 | 5,000 | ||
| 2022-02-08 | SANDERS MACHELLE Director | Grant or award · Non-Qualified Stock Option | +26,667 | 26,667 | ||
| 2022-01-11 | Stonehouse Jon P President & CEO | Option exercise | +184,000 | $4.73 | $870K | 1,085,602 |
| 2022-01-11 | Stonehouse Jon P President & CEO | Sale | −184,000 | $15.04 | $2.8M | 901,602 |
| 2022-01-11 | Stonehouse Jon P President & CEO | Option exercise · Emp. Stock Option (Right to Buy) | −184,000 | 0 | ||
| 2021-12-14 | Doyle Anthony Chief Financial Officer | Grant or award | +75,000 | 168,719 | ||
| 2021-12-14 | Gayer Charles K Chief Commercial Officer | Grant or award | +80,000 | 216,556 | ||
| 2021-12-14 | Barnes Alane P Chief Legal Officer | Grant or award | +55,000 | 201,969 | ||
| 2021-12-14 | Jones Michael L Exec. Director, Finance - PAO | Grant or award | +5,850 | 11,198 | ||
| 2021-12-14 | Jones Michael L Exec. Director, Finance - PAO | Grant or award · Emp. Stock Option (Right to Buy) | +11,700 | 11,700 | ||
| 2021-12-14 | Gayer Charles K Chief Commercial Officer | Grant or award | +125,000 | 261,556 |
Page 17 of 18 · 357 trades